English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy Journal article
Dong, Lei, Zhu, Yini, Zhang, Haoge, Gao, Lin, Zhang, Zhiqi, Xu, Xiaoxuan, Ying, Leqian, Zhang, Lu, Li, Yue, Yun, Zhengcheng, Zhu, Danqi, Han, Chang, Xu, Tingting, Yang, Hui, Ju, Shenghong, Chen, Xiaoyuan, Zhang, Haijun, Xie, Jinbing. Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy[J]. Advanced Materials, 2024.
Authors:  Dong, Lei;  Zhu, Yini;  Zhang, Haoge;  Gao, Lin;  Zhang, Zhiqi; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:27.4/30.2 | Submit date：2024/10/10
Cxcl10  Glioblastoma  Il-2  Immune Checkpoint Inhibitors  Immunosuppressive Microenvironment  Low-frequency Focused Ultrasound  T-cell Exhaustion  
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers Review article
2023
Authors:  Bo Li;  Hui Chen;  Shaohua Yang;  Feng Chen;  Liangliang Xu; et al.
Favorite | TC[WOS]:19 TC[Scopus]:20  IF:27.7/31.3 | Submit date：2023/08/03
Gastrointestinal Cancers  Gastrointestinal Stromal Tumor  Imatinib  Immune Checkpoint Inhibitors  Immunology  Immunotherapy  Model  Resistance  
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments Journal article
Ping Liao, Mengmeng Jiang, Md Sahidul Islam, Yiru Wang, XIN CHEN*. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments[J]. Frontiers in Immunology, 2023, 14, 1097090.
Authors:  Ping Liao;  Mengmeng Jiang;  Md Sahidul Islam;  Yiru Wang;  XIN CHEN*
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:5.7/6.8 | Submit date：2023/08/31
Tnfr2  Immune Checkpoint Inhibitors  Tumor Microenvironment  Cd4 + Foxp3 + Regulatory t Cells  Exhausted Cd8 t Cells  Biomarker  
Editorial: Progress of programmed cell death in antitumor immunity Other
2023-01-01
Authors:  Yan FangFang;  Mao Chao;  Leung Elaine Lai Han;  Luo LianXiang
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/03
Cancer  Ferroptosis  Immune Checkpoint Inhibitors  Immunotherapy  Regulated Cell Death  Tumor Microenvironment  
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma Review article
2023
Authors:  Li, Wenting;  Duan, Xiaobing;  Chen, Xingxing;  Zhan, Meixiao;  Peng, Haichuan; et al.
Favorite | TC[WOS]:28 TC[Scopus]:24  IF:5.7/6.8 | Submit date：2023/02/08
Adoptive Cell Therapy  Ebv-associated Cancer  Ebv-directed Vaccination  Epstein-barr Virus  Immune Checkpoint Inhibitors  Tcr-t Therapy  
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis Journal article
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 260.
Authors:  Huimin Zou;  Qing Lei;  Xin Yan;  Yunfeng Lai;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.5/4.9 | Submit date：2023/02/08
Advanced Hepatocellular Carcinoma  Clinical Outcomes  First-line  Immune Checkpoint Inhibitors  Meta-analysis  
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis Review article
2022
Authors:  Lei, Qing;  Yan, Xin;  Zou, Huimin;  Jiang, Yixuan;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:13 TC[Scopus]:11  IF:2.8/2.8 | Submit date：2023/01/30
First-line  Immune Checkpoint Inhibitors  Meta-analysis  Network Meta-analysis  Unresectable Hepatocellular Carcinoma